Not Found: wait
 

News

 
09/2022

GLA Study Meeting 2022 - Register Now

08/2022

GLA Award 2022 - apply until 15.09.2022

The GLA is proud to announce the GLA Award 2022 “Lymphoma Clinical Research” in honor of Michael Pfreundschuh and the GLA Award 2022 “Lymphoma Biology” and invites young investigators to apply for this awards, which is endowed with 5.000 €.

 

To the call

07/2022

Czernecki Donnelly Preis 2022 awarded

At this year's EHA Annual Meeting in Vienna, PD Dr. Lorenz Thurner, Homburg, was awarded the Czernecki Donnelly Prize 2022, which carries a prize money of € 5,000, for his manuscript on the clinical significance of autoantibodies in mantle cell lymphoma:

LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome

Lorenz Thurner,1 Natalie Fadle,1 Joerg Thomas Bittenbring,1 Evi Regitz,1 Rita Schuck,1 Onur Cetin,1 Ariane Stuhr,2 Torben Rixecker,1 Niels Murawski,1 Viola Poeschel,1 Dominic Kaddu-Mulindwa,1 Klaus-Dieter Preuss,1 Stephan Stilgenbauer,1 Olivier Hermine,2 Hanneke C. Kluin-Nelemans,3 Sylvia Hartmann,4 Martin Dreyling,5 Christiane Pott,6 Moritz Bewarder,1,_ and Eva Hoster5,7,_

blood® 10 JUNE 2021 | VOLUME 137, NUMBER 23, 3251-3258"

 

Congratulations!

04/2022

Fusion of the working groups Biologische Forschung and Pathologie

More information on the newly formed working group "Diagnostik und Biologie" can be found here.

03/2022

Call for GLA Award 2022

The GLA is proud to announce the GLA Award 2022 “Lymphoma Clinical Research” in honor of Michael Pfreundschuh and the GLA Award 2022 “Lymphoma Biology” and invites young investigators to apply for this awards, which is endowed with 5.000 €.

 

To the call

03/2022

Czernecki-Donelly Award 2022

Please send your applications until April 15th 2022.

 

Information

01/2022

Follicular Lymphoma Research Funding Opportunity

The Follicular Lymphoma Foundation is launching a grant program focused on follicular lymphoma research. The Follicular Lymphoma Foundation (FLF) Curative Research to Eliminate Follicular Lymphoma (CURE FL) Awards intend to fund up to four research grants, providing each up to $500,000 over the course of two years to support pre-clinical or clinical research focused on the development of cellular immunotherapy or targeted therapy for FL. The FLF CURE FL Awards are managed and administered by the Milken Institute.

 

The Request for Proposals is published on the FLF's website. We are requesting Letters of Intent by February 4, 2022 via this grant application portal and full proposals will be due on April 15, 2022. If you or researchers at your institution have additional questions, please visit our website or contact our team at CUREFL@milkeninstitute.org. Thank you for your help in spreading the word.